In June 2020, researchers from the University of Szeged, Hungary, reported the development of a carrier-based DPI system, which is an interactive physical blend of a surface-modified carrier and a spray-dried drug with a suitable shape and size for the pulmonary application.
The article cited AMA's "Global Pulmonary Drug Delivery Systems Market Study" explored CAGR of %. According to the report, Technological Advancements in Pulmonary Drug Delivery Systems is one of the primary growth factors for the market. Increasing Incidence of Respiratory Diseases
is also expected to contribute significantly to the Pulmonary Drug Delivery Systems market. Overall, Asthma
applications of Pulmonary Drug Delivery Systems, and the growing awareness of them, is what makes this segment of the industry important to its overall growth. The End User, such as Hospitals & Clinics, is boosting the Pulmonary Drug Delivery Systems market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.
AMAs Analyst on the Global Pulmonary Drug Delivery Systems market identified that the demand is rising in many different parts of the world as "Increase in Research and Developments Activities
". Furthermore, some recent industry insights like "In May 2020, Glenmark Pharmaceuticals announced the launch of a Single Inhaler Triple Therapy AIRZ-FF - a combination of two bronchodilators, Glycopyrronium & Formoterol, and the inhalation corticosteroid Fluticasone propionate, for Chronic Obstructive Pulmonary Disease (COPD)., and In Nov 2019, Drug maker Lupin launched a device to track the usage pattern of metered-dose inhalers (MDI) by patients suffering from chronic respiratory diseases." is constantly making the industry dynamic.
The report provides an in-depth analysis and forecast about the industry covering the following key features: o Industry outlook including current and future market trends, drivers, restraints, and emerging technologies o Analyses the Global Pulmonary Drug Delivery Systems market according to Type, Application, and regions o Analyzes the top 10 players in terms of market reach, business strategy, and business focus o Provides stakeholders insights and key drivers & trends of the market
**The market is valued based on weighted average selling price (WASP) and includes any applicable taxes on manufacturers. All currency conversions used in the creation of this report have been calculated using constant annual average 2018 currency rates.
Market Size Estimation In market engineering method, both top-down and bottom-up approaches have been used, along with various data triangulation process, to predict and validate the market size of the Pulmonary Drug Delivery Systems market and other related sub-markets covered in the study.
o Key & emerging players in the market have been observed through secondary research. o The industrys supply chain and overall market size, in terms of value, have been derived through primary and secondary research processes. o All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Data Triangulation The overall Pulmonary Drug Delivery Systems market size is calculated using market estimation process, the Pulmonary Drug Delivery Systems market was further split into various segments and sub-segments. To complete the overall market engineering and arriving at the exact statistics for all segments and sub-segments, the market breakdown and data triangulation procedures have been utilized, wherever applicable. The data have been triangulated by studying various influencing factors and trends identified from both demand and supply sides of various applications involved in the study. Along with this, the Global Pulmonary Drug Delivery Systems market size has been validated using both top-down and bottom-up approaches.